Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Author:

Murthy Rashmi K.1,Loi Sherene1,Okines Alicia1,Paplomata Elisavet1,Hamilton Erika1,Hurvitz Sara A.1,Lin Nancy U.1,Borges Virginia1,Abramson Vandana1,Anders Carey1,Bedard Philippe L.1,Oliveira Mafalda1,Jakobsen Erik1,Bachelot Thomas1,Shachar Shlomit S.1,Müller Volkmar1,Braga Sofia1,Duhoux Francois P.1ORCID,Greil Richard1,Cameron David1,Carey Lisa A.1,Curigliano Giuseppe1,Gelmon Karen1,Hortobagyi Gabriel1,Krop Ian1,Loibl Sibylle1,Pegram Mark1,Slamon Dennis1,Palanca-Wessels M. Corinna1,Walker Luke1,Feng Wentao1,Winer Eric P.1

Affiliation:

1. From M.D. Anderson Cancer Center, Houston (R.K.M., G.H.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S. Loi); the Royal Marsden NHS Foundation Trust, London (A.O.), and Edinburgh Cancer Research Centre, Edinburgh (D.C.) — both in the United Kingdom; Winship Cancer Institute, Atlanta (E.P.); Sarah Cannon Research Institute/Tennessee Oncology–Nashville (E.H.) and Vanderbilt University Medical Center (V.A.), Nashville; University of California, Los Angeles, Medical Center–Jonsson...

Funder

Seattle Genetics

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3